Variant report

Variant	esv3339374
Chromosome Location	chr8:63160423-63162971
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr8:63162335-63162587	HepG2	liver:	n/a	n/a
2	BACH1	chr8:63162004-63162082	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr8:63161254-63161272	H1-hESC	embryonic stem cell:	n/a	n/a
4	CEBPB	chr8:63162970-63163351	Hela-S3	cervix:	n/a	chr8:63163165-63163178 chr8:63163167-63163178
5	CHD1	chr8:63161096-63161206	H1-hESC	embryonic stem cell:	n/a	n/a
6	CHD2	chr8:63162467-63162593	HepG2	liver:	n/a	n/a
7	CHD2	chr8:63161665-63162207	H1-hESC	embryonic stem cell:	n/a	n/a
8	CHD2	chr8:63160560-63160730	H1-hESC	embryonic stem cell:	n/a	n/a
9	CREB1	chr8:63161387-63161992	A549	lung:	n/a	n/a
10	CTBP2	chr8:63160517-63162469	H1-hESC	embryonic stem cell:	n/a	n/a
11	CTCF	chr8:63160920-63161070	GM12871	blood:	n/a	n/a
12	CTCF	chr8:63160560-63160710	HRE	kidney:	n/a	chr8:63160696-63160705
13	CTCF	chr8:63161840-63161990	HCPEpiC	choroid plexus:	n/a	chr8:63161852-63161865 chr8:63161885-63161898 chr8:63161969-63161982
14	CTCF	chr8:63160663-63160712	HepG2	liver:	n/a	chr8:63160696-63160705
15	CTCF	chr8:63160640-63160790	GM12870	blood:	n/a	chr8:63160696-63160705
16	CTCF	chr8:63160580-63160730	HMF	breast:	n/a	chr8:63160696-63160705
17	CTCF	chr8:63160600-63160750	GM12869	blood:	n/a	chr8:63160696-63160705
18	CTCF	chr8:63160638-63160695	Kidney_OC	kidney:	n/a	n/a
19	CTCF	chr8:63160537-63160804	H1-hESC	embryonic stem cell:	n/a	chr8:63160696-63160705
20	CTCF	chr8:63160599-63160770	H1-hESC	embryonic stem cell:	n/a	chr8:63160696-63160705
21	CTCF	chr8:63161000-63161150	GM12866	blood:	n/a	n/a
22	CTCF	chr8:63160640-63160790	AoAF	blood vessel:	n/a	chr8:63160696-63160705
23	CTCF	chr8:63160597-63160775	Medullo	brain:	n/a	chr8:63160696-63160705
24	CTCF	chr8:63160620-63160770	SAEC	small airway:	n/a	chr8:63160696-63160705
25	CTCF	chr8:63160640-63160790	HPAF	blood vessel:	n/a	chr8:63160696-63160705
26	CTCF	chr8:63161894-63161987	MCF-7	breast:	n/a	chr8:63161969-63161982
27	CTCF	chr8:63160540-63160690	GM12868	blood:	n/a	n/a
28	CTCF	chr8:63160544-63160835	A549	lung:	n/a	chr8:63160696-63160705
29	CTCF	chr8:63161821-63161824	MCF-7	breast:	n/a	n/a
30	CTCF	chr8:63160640-63160759	Fibrobl	skin:	n/a	chr8:63160696-63160705
31	CTCF	chr8:63160580-63160730	GM12869	blood:	n/a	chr8:63160696-63160705
32	CTCF	chr8:63160675-63160723	K562	blood:	n/a	chr8:63160696-63160705
33	CTCF	chr8:63160580-63160730	SK-N-SH_RA	brain:	n/a	chr8:63160696-63160705
34	CTCF	chr8:63160600-63160750	SAEC	small airway:	n/a	chr8:63160696-63160705
35	CTCF	chr8:63160629-63160748	SK-N-SH_RA	brain:	n/a	chr8:63160696-63160705
36	CTCF	chr8:63160624-63160746	ProgFib	skin:	n/a	chr8:63160696-63160705
37	CTCF	chr8:63160640-63160790	NHDF-neo	bronchial:	n/a	chr8:63160696-63160705
38	CTCF	chr8:63160560-63160710	HEEpiC	esophagus:	n/a	chr8:63160696-63160705
39	CTCF	chr8:63160640-63160790	HMEC	breast:	n/a	chr8:63160696-63160705
40	CTCF	chr8:63160620-63160770	WERI-Rb-1	eye:	n/a	chr8:63160696-63160705
41	CTCF	chr8:63160560-63160710	A549	lung:	n/a	chr8:63160696-63160705
42	CTCF	chr8:63160440-63160590	HAc	cerebellar:	n/a	n/a
43	CTCF	chr8:63160560-63160710	Caco-2	colon:	n/a	chr8:63160696-63160705
44	CTCF	chr8:63160600-63160750	AG09319	gingival:	n/a	chr8:63160696-63160705
45	CTCF	chr8:63160580-63160730	AG04450	lung:	n/a	chr8:63160696-63160705
46	CTCF	chr8:63160660-63160810	HAc	cerebellar:	n/a	chr8:63160696-63160705
47	CTCF	chr8:63160620-63160770	HCT-116	colon:	n/a	chr8:63160696-63160705
48	CTCF	chr8:63160600-63160750	HepG2	liver:	n/a	chr8:63160696-63160705
49	CTCF	chr8:63160620-63160770	HRE	kidney:	n/a	chr8:63160696-63160705
50	CTCF	chr8:63160560-63160710	HCT-116	colon:	n/a	chr8:63160696-63160705

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr8:63161616-63161666	HNPCEpiC	eye:	n/a
2	chr8:63160622-63160672	A549	lung:	n/a
3	chr8:63161616-63161666	HNPCEpiC	eye:	n/a
4	chr8:63160622-63160672	A549	lung:	n/a
5	chr8:63161579-63161629	NHBE	bronchial:	n/a
6	chr8:63162277-63162327	HCF	heart:	n/a
7	chr8:63161609-63161659	Hepatocyte	liver:	n/a
8	chr8:63160761-63160811	HRPEpiC	eye:	n/a
9	chr8:63161609-63161659	ovcar-3	ovarian:	n/a
10	chr8:63161077-63161127	HRCEpiC	kidney:	n/a
11	chr8:63160622-63160672	PANC-1	pancreas:	n/a
12	chr8:63161609-63161659	Jurkat	blood:	n/a
13	chr8:63161077-63161127	HCT-116	colon:	n/a
14	chr8:63160622-63160672	BJ	skin:	n/a
15	chr8:63160761-63160811	HRCEpiC	kidney:	n/a
16	chr8:63160761-63160811	HL-60	blood:	n/a
17	chr8:63161077-63161127	H1-hESC	embryonic stem cell:	embryo
18	chr8:63161589-63161639	CMK	blood:	n/a
19	chr8:63161676-63161726	PFSK-1	brain:	n/a
20	chr8:63161676-63161726	HCF	heart:	n/a
21	chr8:63160746-63160796	SK-N-SH	brain:	n/a
22	chr8:63162277-63162327	CMK	blood:	n/a
23	chr8:63160853-63160903	HAEpiC	amniotic membrane:	n/a
24	chr8:63161077-63161127	SK-N-SH_RA	brain:	n/a
25	chr8:63161616-63161666	HepG2	liver:	n/a
26	chr8:63161589-63161639	PFSK-1	brain:	n/a
27	chr8:63160746-63160796	Jurkat	blood:	n/a
28	chr8:63160509-63160559	SAEC	small airway:	n/a
29	chr8:63160746-63160796	NH-A	brain:	n/a
30	chr8:63160853-63160903	NB4	blood:	n/a
31	chr8:63161676-63161726	SKMC	muscle:	n/a
32	chr8:63160547-63160597	HNPCEpiC	eye:	n/a
33	chr8:63161676-63161726	AG04450	lung:	fetal
34	chr8:63161616-63161666	Jurkat	blood:	n/a
35	chr8:63162277-63162327	PFSK-1	brain:	n/a
36	chr8:63160853-63160903	ovcar-3	ovarian:	n/a
37	chr8:63161077-63161127	NHBE	bronchial:	n/a
38	chr8:63160509-63160559	HRPEpiC	eye:	n/a
39	chr8:63161589-63161639	AG10803	skin:	n/a
40	chr8:63160761-63160811	HCPEpiC	choroid plexus:	n/a
41	chr8:63161579-63161629	Hepatocyte	liver:	n/a
42	chr8:63160547-63160597	Jurkat	blood:	n/a
43	chr8:63161676-63161726	HAEpiC	amniotic membrane:	n/a
44	chr8:63161616-63161666	AoSMC	blood vessel:	n/a
45	chr8:63161077-63161127	RPTEC	kidney:	n/a
46	chr8:63160761-63160811	GM06990	blood:	n/a
47	chr8:63160761-63160811	HCF	heart:	n/a
48	chr8:63160547-63160597	GM06990	blood:	n/a
49	chr8:63161609-63161659	GM06990	blood:	n/a
50	chr8:63161579-63161629	HRCEpiC	kidney:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr8:63157703..63161119-chr8:63165423..63168636,3	K562	blood:

Variant related genes	Relation type
NKAIN3	TF binding region
NKAIN3	CpG island

Extended variants
information (count: 100 )
Associated
traits (count: 95 )

Variant overlapped rSNPs/rCNVs (count:100 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1483177	chr8:63160490-63160491	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs564456084	chr8:63160507-63160508	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs528719622	chr8:63160509-63160510	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
4	rs547176568	chr8:63160568-63160569	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
5	rs369890511	chr8:63160578-63160579	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
6	rs568609530	chr8:63160583-63160584	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
7	rs142900282	chr8:63160588-63160589	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
8	rs529483118	chr8:63160617-63160618	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs530215170	chr8:63160625-63160626	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
10	rs569354685	chr8:63160638-63160639	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
11	rs539854542	chr8:63160731-63160732	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs372449886	chr8:63160806-63160807	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
13	rs570759608	chr8:63160811-63160812	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
14	rs534655647	chr8:63160812-63160813	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs184795393	chr8:63160815-63160816	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs574579867	chr8:63160821-63160822	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs189403404	chr8:63160858-63160859	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
18	rs371391047	chr8:63160907-63160908	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs375800407	chr8:63160965-63160966	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs145240577	chr8:63160991-63160992	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs574960606	chr8:63161010-63161011	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs12549042	chr8:63161013-63161014	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs368972546	chr8:63161107-63161108	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
24	rs551380048	chr8:63161119-63161120	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
25	rs375238581	chr8:63161214-63161215	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs146887164	chr8:63161215-63161216	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs528088178	chr8:63161238-63161239	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs55794340	chr8:63161239-63161240	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs540612438	chr8:63161241-63161242	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs370674047	chr8:63161271-63161272	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs374374385	chr8:63161309-63161310	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs529494409	chr8:63161331-63161332	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs551170615	chr8:63161370-63161371	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs2272015	chr8:63161382-63161383	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs533427615	chr8:63161429-63161430	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs375889403	chr8:63161446-63161447	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs2272014	chr8:63161462-63161463	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs566919768	chr8:63161491-63161492	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs534177275	chr8:63161513-63161514	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs553027610	chr8:63161545-63161546	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs568311171	chr8:63161563-63161564	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs535311931	chr8:63161590-63161591	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
43	rs2272013	chr8:63161612-63161613	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
44	rs575004635	chr8:63161676-63161677	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs374585193	chr8:63161684-63161685	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs368332166	chr8:63161704-63161705	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs572775939	chr8:63161714-63161715	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs181957798	chr8:63161727-63161728	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs569275307	chr8:63161729-63161730	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs574231094	chr8:63161737-63161738	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:95)

Disease	PMID	Source
Cancer	16751803	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Ewing''s sarcoma	21437220	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Seminomas	18059402	CNVD
Autism	22495311	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Pancreatic cancer	21811587	CNVD
Thyroid cancer	19087340	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	17603634	CNVD
Disorders of sex development	21048976	CNVD
Testicular cancer	18059402	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21509527	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Cancer	20164919	CNVD
primary effusion lymphomas	17116491	CNVD
Esophageal cancer	20955586	CNVD
Multiple myeloma	16461302	CNVD
abnormal development	18461090	CNVD
Cancer	20164920	CNVD
Oral cancer	21386901	CNVD
Uveal melanoma	21693616	CNVD
Langer-Giedion syndrome	22283845	CNVD
Cancer	21637783	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	20632083	CNVD
Breast cancer	19602461	CNVD
Cancer	22429812	CNVD
Endometrial cancer	22040021	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oral cancer	19627613	CNVD
Prostate cancer	21088497	CNVD
colon cancer	17210682	CNVD
Breast cancer	21264507	CNVD
Breast cancer	22028636	CNVD
Acute myeloid leukemia	16864856	CNVD
Salivary gland tumor	18059337	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Gastric cancer	17167181	CNVD
Colorectal cancer	19359472	CNVD
Breast cancer	16461572	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
head and neck squamous cell carcinoma	18028549	CNVD
Breast cancer	17001317	CNVD
Ewing''s sarcoma	17952124	CNVD
Urothelial carcinoma	21177765	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	16608533	CNVD
Metanephric adenoma	20802469	CNVD
Hepatocellular carcinoma	18803288	CNVD
Prostate cancer	18632612	CNVD
Glioblastoma multiforme	18628472	CNVD
Ovarian cancer	22174824	CNVD
Prostate cancer	16573809	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Colorectal cancer	16272173	CNVD
Melanoma	22183965	CNVD
Cancer	21949371	CNVD
Non-small cell lung cancer	21829676	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Acute myeloid leukemia	21358987	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Adenocarcinoma	21044232	CNVD
Squamous cell cancer	20885788	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
small cell lung cancer	20016488	CNVD
Sezary syndrome	18413736	CNVD
Colorectal cancer	21645411	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD

Chromatin state (count:317 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:63155400-63160600	Weak transcription	Pancreas	Pancrea
2	chr8:63159200-63163800	Active TSS	Fetal Brain Female	brain
3	chr8:63159600-63161600	Bivalent/Poised TSS	Brain Hippocampus Middle	brain
4	chr8:63159600-63162800	Active TSS	Brain Anterior Caudate	brain
5	chr8:63159800-63161600	Active TSS	Brain Inferior Temporal Lobe	brain
6	chr8:63159800-63163000	Active TSS	Fetal Brain Male	brain
7	chr8:63160000-63160600	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
8	chr8:63160000-63160600	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
9	chr8:63160000-63160600	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
10	chr8:63160000-63161600	Active TSS	Stomach Smooth Muscle	stomach
11	chr8:63160000-63162000	Active TSS	Ovary	ovary
12	chr8:63160000-63162000	Active TSS	Skeletal Muscle Male	skeletal muscle
13	chr8:63160000-63162200	Active TSS	Foreskin Melanocyte Primary Cells skin01	Skin
14	chr8:63160000-63162400	Active TSS	Cortex derived primary cultured neurospheres	brain
15	chr8:63160000-63162400	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
16	chr8:63160000-63162400	Bivalent/Poised TSS	Brain Substantia Nigra	brain
17	chr8:63160200-63160600	Flanking Bivalent TSS/Enh	H9 Derived Neuron Cultured Cells	ES cell derived
18	chr8:63160200-63160600	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells	blood
19	chr8:63160200-63160800	Bivalent/Poised TSS	iPS DF 19.11 Cell Line	embryonic stem cell
20	chr8:63160200-63160800	Bivalent/Poised TSS	ES-UCSF4 Cell Line	embryonic stem cell
21	chr8:63160200-63160800	Bivalent/Poised TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
22	chr8:63160200-63161600	Bivalent Enhancer	Sigmoid Colon	Sigmoid Colon
23	chr8:63160200-63161800	Active TSS	Breast Myoepithelial Primary Cells	Breast
24	chr8:63160200-63161800	Bivalent/Poised TSS	Brain Dorsolateral Prefrontal Cortex	brain
25	chr8:63160200-63161800	Bivalent/Poised TSS	Duodenum Smooth Muscle	Duodenum
26	chr8:63160200-63162000	Active TSS	Muscle Satellite Cultured Cells	--
27	chr8:63160200-63162000	Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
28	chr8:63160200-63162000	Bivalent/Poised TSS	Brain Cingulate Gyrus	brain
29	chr8:63160200-63162000	Bivalent/Poised TSS	Fetal Intestine Small	intestine
30	chr8:63160200-63162200	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
31	chr8:63160200-63162200	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
32	chr8:63160200-63162200	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Female	--
33	chr8:63160200-63162200	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
34	chr8:63160200-63162200	Bivalent/Poised TSS	Skeletal Muscle Female	skeletal muscle
35	chr8:63160200-63162400	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
36	chr8:63160200-63162400	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
37	chr8:63160200-63162400	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
38	chr8:63160200-63162400	Active TSS	Brain Angular Gyrus	brain
39	chr8:63160200-63162400	Bivalent/Poised TSS	Rectal Mucosa Donor 29	rectum
40	chr8:63160200-63162400	Active TSS	Rectal Smooth Muscle	rectum
41	chr8:63160200-63162800	Active TSS	Fetal Kidney	kidney
42	chr8:63160400-63160600	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
43	chr8:63160400-63160600	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
44	chr8:63160400-63160600	Bivalent/Poised TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
45	chr8:63160400-63160600	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
46	chr8:63160400-63160600	Active TSS	Fetal Adrenal Gland	Adrenal Gland
47	chr8:63160400-63160600	Bivalent Enhancer	Lung	lung
48	chr8:63160400-63160600	Active TSS	Psoas Muscle	Psoas
49	chr8:63160400-63160600	Flanking Bivalent TSS/Enh	HSMM	muscle
50	chr8:63160400-63160600	Flanking Bivalent TSS/Enh	Osteobl	bone

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links